Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections

导出原文传递

翻译打印收藏纠错

作者： Rashid, A. Nassar-Sheikh ^[1] ; Bergkamp, S. C. ; Kampinga, R. E. ; Gouw, S. C. ; Bouts, A. H. M. ; Oosterveld, M. J. S. ; Baars, P. A. ; van Leeuwen, E. M. M. ; Kuijpers, T. W. ; van den Berg, J. M. ; Schonenberg-Meinema, D.

作者单位： Ctr Hosp Univ PortoUniv Lorraine Ctr Invest Clin Plurithemat 1433 INSERM CHRU Nancy,Inserm U1116 F ^[1]

关键词 rituximab children B cell depletion hypogammaglobulinaemia infections SYSTEMIC-LUPUS-ERYTHEMATOSUS RHEUMATOID-ARTHRITIS THERAPY SAFETY EFFICACY COMPLICATIONS ANTIBODIES INDUCTION CHILDREN TRIAL

发布时间 2024-05-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and experimental rheumatology

2023年41卷11期

2323-2330页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections

Clinical and experimental rheumatology

相似文献

Clinical and experimental rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections

Clinical and experimental rheumatology

相似文献

Clinical and experimental rheumatology

相关期刊

检索历史清除